Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:288-290
Published online before print January 12, 2006, doi: 10.1161/01.STR.0000200449.58684.8a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/2/288    most recent
01.STR.0000200449.58684.8av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markus, H. S.
Right arrow Articles by Alberts, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markus, H. S.
Right arrow Articles by Alberts, M. J.
Related Collections
Right arrow Genetics of cardiovascular disease

(Stroke. 2006;37:288.)
© 2006 American Heart Association, Inc.


Advances in Stroke 2005

Update on Genetics of Stroke and Cerebrovascular Disease 2005

Hugh S. Markus, FRCP Mark J. Alberts, MD

From the Clinical Neuroscience (H.S.M.), St Georges, University of London, London, UK; and the Department of Neurology (M.J.A.), Northwestern University, Feinberg School of Medicine, Chicago, IL.

Correspondence to Hugh S. Markus, Centre for Clinical Neuroscience, St Georges, University of London, Cranmer Terrace, London SW17 ORW. E-mail h.markus@sgul.ac.uk


Key Words: CADASIL • genetics • stroke


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Over the past 2 years this update reported the identification by the Icelandic Decode group of 2 novel genes associated with ischemic stroke: phosphodiesterase 4D gene (PDE4D) and 5-Lipoxygenase activating protein (ALOX5AP).1,2 These putative associations have been with specific haplotypes of each gene, but no disease-specific mutations in either gene have been identified.

PDE4D, a cyclic nucleotide phosphodiesterase, selectively degrades second messenger cAMP (cAMP). Reduced cAMP levels are associated with increased smooth muscle cell proliferation and migration, key events in atherosclerosis, making an association with stroke pathophysiologically plausible. Consistent with this, the initial association was reported only with large artery and cardioembolic stroke subtypes.2 Studies over the last year attempting to replicate this association have produced diverse results. In a UK population no overall association was found with ischemic stroke, but possible associations were identified with cardioembolic and large artery stroke.3 An American study reported an association with ischemic stroke, particularly large artery stroke.4 In contrast, no association was found in a German stroke cohort,5 or a Swedish stroke cohort aged <75 years.6 A linkage study from a second Swedish population confirmed linkage to 5q12,6 but no linkage study could be found in an American population.4 No association was found with carotid intima-media thickness,3 suggesting PDE4D does not exert its effects via accelerating early atherosclerosis.

ALOX5AP codes for 5-lipoxygenase activating protein which is essential for conversion of arachadonic acid to leukotriene A4, a process catabolized by 5-lipooxygenase. LTA4 is converted into LTB4, which plays . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
The European Registers of Stroke (EROS) Investigat
Incidence of Stroke in Europe at the Beginning of the 21st Century
Stroke, May 1, 2009; 40(5): 1557 - 1563.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. C. Smeeton, P. U. Heuschmann, A. G. Rudd, A. W. McEvoy, N. D. Kitchen, S. J. Sarker, and C. D.A. Wolfe
Incidence of Hemorrhagic Stroke in Black Caribbean, Black African, and White Populations: The South London Stroke Register, 1995 2004
Stroke, December 1, 2007; 38(12): 3133 - 3138.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Lee and M. Kong
An Interactive Association of Common Sequence Variants in the Neuropeptide Y Gene With Susceptibility to Ischemic Stroke
Stroke, October 1, 2007; 38(10): 2663 - 2669.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. P. Koerner, R. Jacks, A. E. DeBarber, D. Koop, P. Mao, D. F. Grant, and N. J. Alkayed
Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury
J. Neurosci., April 25, 2007; 27(17): 4642 - 4649.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. van Leyen, H. Y. Kim, S.-R. Lee, G. Jin, K. Arai, and E. H. Lo
Baicalein and 12/15-Lipoxygenase in the Ischemic Brain
Stroke, December 1, 2006; 37(12): 3014 - 3018.
[Abstract] [Full Text] [PDF]